Access the full text.
Sign up today, get DeepDyve free for 14 days.
Jameson Rm (1976)
Recurrent urinary tract infection in women.Nursing mirror and midwives journal, 143 4
X. Albert, Isabel Huertas, Inmaculado Pereiro, J. Sanfélix, V. Gosalbes, C. Perrotta (2004)
Antibiotics for preventing recurrent urinary tract infection in non-pregnant women.The Cochrane database of systematic reviews, 3
(1985)
Man - agement of recurrent urinary tract infections with patientadministered singledose therapy
Patrick Smith, J. Blumenthal, M. Babyak, L. Craighead, K. Welsh-Bohmer, Jeffrey Browndyke, Timothy Strauman, A. Sherwood (2010)
Effects of the Dietary Approaches to Stop Hypertension Diet, Exercise, and Caloric Restriction on Neurocognition in Overweight Adults With High Blood PressureHypertension, 55
Patrick Smith, J. Blumenthal, B. Hoffman, H. Cooper, Timothy Strauman, K. Welsh-Bohmer, Jeffrey Browndyke, A. Sherwood (2010)
Aerobic Exercise and Neurocognitive Performance: A Meta-Analytic Review of Randomized Controlled TrialsPsychosomatic Medicine, 72
B. Cunha (2001)
Effective antibiotic-resistance control strategiesThe Lancet, 357
S. Fihn (2003)
Clinical practice. Acute uncomplicated urinary tract infection in women.The New England journal of medicine, 349 3
N. Scarmeas, J. Luchsinger, N. Schupf, A. Brickman, Stephanie Cosentino, M. Tang, Y. Stern (2009)
Physical activity, diet, and risk of Alzheimer disease.JAMA, 302 6
M. Beerepoot, G. Riet, S. Nys, W. Wal, C. Borgie, T. Reijke, J. Prins, J. Koeijers, A. Verbon, E. Stobberingh, S. Geerlings (2011)
Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women.Archives of internal medicine, 171 14
B. Cunha (2006)
The clinical significance of resistant uropathogens in ambulatory urinary tract infections in womenScandinavian Journal of Infectious Diseases, 38
Burke Cunha (1988)
Nitrofurantoin--current concepts.Urology, 32 1
M. Vercambre, F. Grodstein, J. Manson, M. Stampfer, J. Kang (2011)
Physical activity and cognition in women with vascular conditions.Archives of internal medicine, 171 14
J. Mendez, Hassan Nadrous, T. Hartman, J. Ryu (2005)
Chronic nitrofurantoin-induced lung disease.Mayo Clinic proceedings, 80 10
C. McOsker, Penny Fitzpatrick (1994)
Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens.The Journal of antimicrobial chemotherapy, 33 Suppl A
M. Roizen (2012)
Activity Energy Expenditure and Incident Cognitive Impairment in Older AdultsYearbook of Anesthesiology and Pain Management, 2012
I read with interest the article by Beerepoot et al1 on urinary tract infection (UTI) prophylaxis, which raises important points that merit comment. From a resistance perspective, the article re-emphasizes that trimethoprim-sulfamethoxazole (TMP-SMX) is a “high resistance potential” antibiotic that predisposes to resistance among uropathogens. Clinicians should be reminded that resistance is not related to antibiotic volume, duration, or class per se, but rather is associated with individual agents from all antibiotic classes.2 Nitrofurantoin does not predispose to uropathogen resistance for prophylaxis and therapy of short or long duration.3 Another point deserving re-emphasis is that antibiotics with a high resistance potential not only predispose to increased resistance during treatment but such resistant uropathogens may persist in fecal flora for up to 3 months following therapy. Clinicians should take great care in selecting an appropriate antibiotic with a low resistance potential, both to minimize the resistance potential and to prevent prolonged carriage of resistant uropathogens in the fecal flora.2 The study was intended to determine if cranberry juice had antibacterial effects. However, the most important take home message is to avoid TMP-SMX for prophylaxis or therapy of recurrent UTIs.1 Instead, use nitrofurantoin, which is effective against most common uropathogens but does not predispose to resistance. Nitrofurantoin is effective against common uropathogens except Proteus species and Pseudomonas aeruginosa. Nitrofurantoin inhibits bacterial growth at 3 different loci in the Kreb's cycle of susceptible uropathogens.3 Nitrofurantoin, rather than TMP-SMX, is ideal for prophylaxis of recurrent lower UTIs and acute complicated cystitis in female patients.4 Another concern in the study is timing and duration of prophylaxis for recurrent UTIs. Excluding relapsing UTIs, reinfecting recurrent UTIs are best treated episodically with a “low resistance potential” antibiotic, eg, nitrofurantoin. It is preferable to treat a few episodes of cystitis per year as needed rather than to use prolonged prophylaxis with TMP-SMX with its associated costs and risks of adverse effects, eg, drug fever, Steven-Johnson syndrome, folate deficiency, cost of resistance, and prolonged carriage of uropathogens in the fecal flora. In my clinical experience, nitrofurantoin has been useful for empirical initial prophylaxis and treatment of recurrent lower UTIs in women. The adverse effects of nitrofurantoin occur mainly with prolonged therapy with chronic renal insufficiency. Nitrofurantoin is a cost-effective and safe alternative to TMP-SMX and does not predispose to resistance.2,5 Clinicians should carefully consider the resistance potential of antibiotics selected for recurrent UTIs. Better alternatives than TMP-SMX, eg, nitrofurantoin, are available and have a long record of effectiveness and lack of resistance. Back to top Article Information Correspondence: Dr Cunha, Chief, Infectious Disease Division, Winthrop-University Hospital, 222 Station Plaza N (Ste 432), Mineola, NY 11501 (bacunha@winthrop.org). Financial Disclosure: None reported. References 1. Beerepoot MA, ter Riet G, Nys S, et al. Cranberries vs antibiotics to prevent urinary tract infections: a randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med. 2011;171(14):1270-127821788542PubMedGoogle ScholarCrossref 2. Cunha BA. Effective antibiotic-resistance control strategies. Lancet. 2001;357(9265):1307-130811343730PubMedGoogle ScholarCrossref 3. Cunha BA. Nitrofurantoin—current concepts. Urology. 1988;32(1):67-713291373PubMedGoogle ScholarCrossref 4. McOsker CC, Fitzpatrick PM. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother. 1994;33:(suppl A) 23-307928834PubMedGoogle Scholar 5. Cunha BA. The clinical significance of resistant uropathogens in ambulatory urinary tract infections in women. Scand J Infect Dis. 2006;38(3):235-23616500792PubMedGoogle ScholarCrossref
Archives of Internal Medicine – American Medical Association
Published: Jan 9, 2012
Keywords: nitrofurantoin,trimethoprim-sulfamethoxazole combination,recurrent urinary tract infections,cranberry preparations
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.